Spero Therapeutics (SPRO) Cash from Operations Growth (1y) (2017 - 2026)
Spero Therapeutics (SPRO) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Spero Therapeutics |
156.67 Mn |
100.54 Mn |
- |
496.40% |
| Date | Value |
|---|
| Mar 31, 2026 |
496.40% |
| Dec 31, 2025 |
64.31% |
| Sep 30, 2025 |
36.50% |
| Jun 30, 2025 |
5.61% |
| Mar 31, 2025 |
-167.40% |
| Dec 31, 2024 |
-33.77% |
| Sep 30, 2024 |
-19.81% |
| Jun 30, 2024 |
-0.97% |
| Mar 31, 2024 |
146.20% |
| Dec 31, 2023 |
-139.33% |
| Sep 30, 2023 |
1,763.01% |
| Jun 30, 2023 |
19.40% |
| Mar 31, 2023 |
54.46% |
| Dec 31, 2022 |
262.65% |
| Sep 30, 2022 |
80.67% |
| Jun 30, 2022 |
-39.03% |
| Mar 31, 2022 |
-82.33% |
| Dec 31, 2021 |
-66.94% |
| Sep 30, 2021 |
76.71% |
| Jun 30, 2021 |
33.46% |
